A novel small binding protein that targets PCSK9
This video was recorded during the virtual 2020 EAS Congress.
Prof. Evan Stein, LIB Therapeutics and Metabolic & Atherosclerosis Research Center, Cincinnati, OH, USA.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: